Industrivarden AB
F:IDVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Industrivarden AB
F:IDVA
|
SE |
|
Home BancShares Inc
NYSE:HOMB
|
US |
|
P
|
Parque Arauco SA
SGO:PARAUCO
|
CL |
|
Criteo SA
NASDAQ:CRTO
|
FR |
|
D
|
Deutsche Bank AG
XMUN:DBK
|
DE |
|
Noritake Co Ltd
F:NO4
|
JP |
|
C
|
Ctac NV
LSE:0E2F
|
NL |
|
US GoldMining Inc
F:Q0G
|
CA |
|
M
|
Murphy Oil Corp
XBER:MUQ
|
US |
|
D
|
Dupont De Nemours Inc
SWB:6D81
|
US |
|
S
|
Shandong Linuo Technical Glass Co Ltd
SZSE:301188
|
CN |
|
M
|
Masco Corp
XMUN:MSQ
|
US |
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
IN |
|
A
|
Abercrombie & Fitch Co
XMUN:AFT
|
US |
|
3
|
3U Holding AG
XETRA:UUU
|
DE |
|
Swiss Prime Site AG
XETRA:SU1N
|
CH |
|
M
|
Morgan Stanley
LSE:0QYU
|
US |
|
Dufry AG
F:D2J
|
CH |
|
Capita PLC
F:CTA0
|
UK |
|
S
|
Syzygy AG
XBER:SYZ
|
DE |
|
DT Midstream Inc
NYSE:DTM
|
US |
Balance Sheet
Balance Sheet Decomposition
Industrivarden AB
Industrivarden AB
Balance Sheet
Industrivarden AB
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
5
|
823
|
613
|
786
|
56
|
0
|
697
|
795
|
869
|
843
|
1 343
|
|
| Cash Equivalents |
5
|
823
|
613
|
786
|
56
|
0
|
697
|
795
|
869
|
843
|
1 343
|
|
| Total Receivables |
210
|
325
|
442
|
267
|
182
|
168
|
55
|
97
|
62
|
59
|
51
|
|
| Other Current Assets |
21
|
12
|
4
|
6
|
9
|
28
|
27
|
18
|
23
|
19
|
19
|
|
| Total Current Assets |
236
|
1 160
|
1 059
|
1 059
|
247
|
196
|
779
|
910
|
954
|
921
|
1 413
|
|
| PP&E Net |
0
|
13
|
12
|
11
|
14
|
21
|
18
|
14
|
25
|
19
|
14
|
|
| PP&E Gross |
0
|
13
|
12
|
11
|
14
|
21
|
18
|
14
|
25
|
19
|
14
|
|
| Accumulated Depreciation |
0
|
1
|
2
|
3
|
9
|
5
|
10
|
15
|
4
|
9
|
14
|
|
| Note Receivable |
466
|
201
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
81 835
|
94 250
|
107 289
|
92 170
|
116 750
|
128 893
|
149 955
|
133 832
|
157 547
|
166 504
|
197 473
|
|
| Total Assets |
82 537
N/A
|
95 624
+16%
|
108 360
+13%
|
93 240
-14%
|
117 011
+25%
|
129 110
+10%
|
150 752
+17%
|
134 756
-11%
|
158 526
+18%
|
167 444
+6%
|
198 900
+19%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
1
|
1
|
4
|
3
|
4
|
3
|
4
|
4
|
5
|
3
|
2
|
|
| Accrued Liabilities |
187
|
140
|
119
|
116
|
83
|
95
|
104
|
133
|
149
|
139
|
150
|
|
| Short-Term Debt |
1 649
|
5 425
|
3 023
|
4 644
|
1 132
|
2 018
|
220
|
182
|
0
|
496
|
0
|
|
| Current Portion of Long-Term Debt |
500
|
0
|
1 500
|
750
|
800
|
1 251
|
1 500
|
1 500
|
1 691
|
2 289
|
2 284
|
|
| Other Current Liabilities |
65
|
133
|
174
|
379
|
4
|
5
|
60
|
71
|
24
|
38
|
51
|
|
| Total Current Liabilities |
2 402
|
5 699
|
4 820
|
5 892
|
2 023
|
3 372
|
1 888
|
1 890
|
1 869
|
2 965
|
2 487
|
|
| Long-Term Debt |
11 058
|
7 260
|
7 170
|
2 059
|
2 255
|
4 507
|
5 504
|
6 500
|
6 509
|
5 004
|
5 000
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
93
|
140
|
164
|
134
|
228
|
228
|
284
|
|
| Other Liabilities |
1 227
|
536
|
490
|
147
|
112
|
115
|
117
|
52
|
40
|
69
|
111
|
|
| Total Liabilities |
14 687
N/A
|
13 495
-8%
|
12 480
-8%
|
8 098
-35%
|
4 483
-45%
|
8 134
+81%
|
7 673
-6%
|
8 576
+12%
|
8 646
+1%
|
8 266
-4%
|
7 882
-5%
|
|
| Equity | ||||||||||||
| Common Stock |
1 081
|
1 081
|
1 088
|
1 088
|
1 088
|
1 088
|
1 088
|
1 088
|
1 088
|
1 088
|
1 088
|
|
| Retained Earnings |
66 769
|
81 048
|
94 792
|
84 054
|
111 440
|
119 888
|
141 991
|
125 092
|
148 792
|
158 090
|
189 930
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
149 880
|
159 178
|
0
|
|
| Total Equity |
67 850
N/A
|
82 129
+21%
|
95 880
+17%
|
85 142
-11%
|
112 528
+32%
|
120 976
+8%
|
143 079
+18%
|
126 180
-12%
|
149 880
+19%
|
159 178
+6%
|
191 018
+20%
|
|
| Total Liabilities & Equity |
82 537
N/A
|
95 624
+16%
|
108 360
+13%
|
93 240
-14%
|
117 011
+25%
|
129 110
+10%
|
150 752
+17%
|
134 756
-11%
|
158 526
+18%
|
167 444
+6%
|
198 900
+19%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
432
|
432
|
435
|
435
|
435
|
435
|
432
|
432
|
432
|
432
|
432
|
|